Axogen, Inc. Diluted Shares Outstanding (Weighted Average)
Axogen, Inc. (AXGN) reported Diluted Shares Outstanding (Weighted Average) of 53.34 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-07-29
- Axogen, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 53.34M shares, a 11.17% increase year-over-year.
- Axogen, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 51.59M shares, a 14.13% increase year-over-year.
- Axogen, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 46.49M shares, a 0.62% increase year-over-year.
- Axogen, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 49.09M shares, a 11.86% increase year-over-year.
- Axogen, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 46.05M shares, a 4.05% increase from fiscal 2024.
- Axogen, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 44.26M shares, a 3.22% increase from fiscal 2023.
- Axogen, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 42.88M shares, a 1.89% increase from fiscal 2022.
- Axogen, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 42.08M shares, a 2.11% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 53.34M shares 10-Q · filed 2026-07-29 | 52.56M shares 10-Q · filed 2026-07-29 | 50.47M shares derived: average of 3 quarters · filed 2026-07-29 | 50.13M shares derived: average of 4 quarters · filed 2026-07-29 | |
| 2026-03-31 | 51.59M shares 10-Q · filed 2026-04-28 | 49.04M shares derived: average of 2 quarters · filed 2026-04-28 | 49.06M shares derived: average of 3 quarters · filed 2026-04-28 | 48.79M shares derived: average of 4 quarters · filed 2026-07-29 | |
| 2025-12-31 | 46.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 47.79M shares derived: average of 2 quarters · filed 2026-02-24 | 47.85M shares derived: average of 3 quarters · filed 2026-07-29 | 46.05M shares 10-K · filed 2026-02-24 | |
| 2025-09-30 | 49.09M shares 10-Q · filed 2025-10-29 | 48.53M shares derived: average of 2 quarters · filed 2026-07-29 | 45.91M shares 10-Q · filed 2025-10-29 | 47.12M shares derived: average of 4 quarters · filed 2026-07-29 | |
| 2025-06-30 | 47.98M shares 10-Q · filed 2026-07-29 | 45.61M shares 10-Q · filed 2026-07-29 | 46.46M shares derived: average of 3 quarters · filed 2026-07-29 | 45.82M shares derived: average of 4 quarters · filed 2026-07-29 | |
| 2025-03-31 | 45.20M shares 10-Q · filed 2026-04-28 | 45.70M shares derived: average of 2 quarters · filed 2026-04-28 | 45.10M shares derived: average of 3 quarters · filed 2026-04-28 | 44.75M shares derived: average of 4 quarters · filed 2026-04-28 | |
| 2024-12-31 | 46.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 45.04M shares derived: average of 2 quarters · filed 2026-02-24 | 44.60M shares derived: average of 3 quarters · filed 2026-02-24 | 44.26M shares 10-K · filed 2026-02-24 | |
| 2024-09-30 | 43.88M shares 10-Q · filed 2025-10-29 | 43.80M shares derived: average of 2 quarters · filed 2025-10-29 | 43.61M shares 10-Q · filed 2025-10-29 | 43.47M shares derived: average of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | 43.71M shares 10-Q · filed 2025-08-05 | 43.47M shares 10-Q · filed 2025-08-05 | 43.33M shares derived: average of 3 quarters · filed 2026-02-24 | 43.25M shares derived: average of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | 43.23M shares 10-Q · filed 2025-05-08 | 43.14M shares derived: average of 2 quarters · filed 2026-02-24 | 43.10M shares derived: average of 3 quarters · filed 2026-02-24 | 43.04M shares derived: average of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | 43.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 43.04M shares derived: average of 2 quarters · filed 2026-02-24 | 42.98M shares derived: average of 3 quarters · filed 2026-02-24 | 42.88M shares 10-K · filed 2026-02-24 | |
| 2023-09-30 | 43.02M shares 10-Q · filed 2024-11-07 | 42.94M shares derived: average of 2 quarters · filed 2024-11-07 | 42.82M shares 10-Q · filed 2024-11-07 | 42.69M shares derived: average of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | 42.86M shares 10-Q · filed 2024-08-08 | 42.72M shares 10-Q · filed 2024-08-08 | 42.58M shares derived: average of 3 quarters · filed 2025-02-26 | 42.49M shares derived: average of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | 42.57M shares 10-Q · filed 2024-05-02 | 42.44M shares derived: average of 2 quarters · filed 2025-02-26 | 42.37M shares derived: average of 3 quarters · filed 2025-02-26 | 42.27M shares derived: average of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | 42.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 42.26M shares derived: average of 2 quarters · filed 2025-02-26 | 42.17M shares derived: average of 3 quarters · filed 2025-02-26 | 42.08M shares 10-K · filed 2025-02-26 | |
| 2022-09-30 | 42.22M shares 10-Q · filed 2023-11-07 | 42.11M shares derived: average of 2 quarters · filed 2023-11-07 | 42.01M shares 10-Q · filed 2023-11-07 | 41.90M shares derived: average of 4 quarters · filed 2024-03-05 | |
| 2022-06-30 | 41.99M shares 10-Q · filed 2023-08-08 | 41.90M shares 10-Q · filed 2023-08-08 | 41.80M shares derived: average of 3 quarters · filed 2024-03-05 | 41.72M shares derived: average of 4 quarters · filed 2024-03-05 | |
| 2022-03-31 | 41.80M shares 10-Q · filed 2023-05-09 | 41.70M shares derived: average of 2 quarters · filed 2024-03-05 | 41.62M shares derived: average of 3 quarters · filed 2024-03-05 | 41.49M shares derived: average of 4 quarters · filed 2024-03-05 | |
| 2021-12-31 | 41.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 41.53M shares derived: average of 2 quarters · filed 2024-03-05 | 41.38M shares derived: average of 3 quarters · filed 2024-03-05 | 41.21M shares 10-K · filed 2024-03-05 | 41.22M shares 10-K · filed 2022-02-25 |
| 2021-09-30 | 41.47M shares 10-Q · filed 2022-11-08 | 41.27M shares derived: average of 2 quarters · filed 2022-11-08 | 41.09M shares 10-Q · filed 2022-11-08 | 40.88M shares derived: average of 4 quarters · filed 2023-03-14 | |
| 2021-06-30 | 41.08M shares 10-Q · filed 2022-08-05 | 40.89M shares 10-Q · filed 2022-08-05 | 40.68M shares derived: average of 3 quarters · filed 2023-03-14 | 40.53M shares derived: average of 4 quarters · filed 2023-03-14 | |
| 2021-03-31 | 40.71M shares 10-Q · filed 2022-05-05 | 40.48M shares derived: average of 2 quarters · filed 2023-03-14 | 40.35M shares derived: average of 3 quarters · filed 2023-03-14 | 40.22M shares derived: average of 4 quarters · filed 2023-03-14 | |
| 2020-12-31 | 40.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 40.17M shares derived: average of 2 quarters · filed 2023-03-14 | 40.06M shares derived: average of 3 quarters · filed 2023-03-14 | 39.97M shares 10-K · filed 2023-03-14 | 39.97M shares 10-K · filed 2022-02-25 |
| 2020-09-30 | 40.09M shares 10-Q · filed 2021-11-04 | 39.96M shares derived: average of 2 quarters · filed 2021-11-04 | 39.87M shares 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | 39.82M shares 10-Q · filed 2021-08-05 | 39.76M shares 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | 39.23M shares 10-K · filed 2022-02-25 | ||||
| 2011-06-30 | 4.31M shares 10-Q/A · filed 2011-09-09 | 4.31M shares 10-Q/A · filed 2011-09-09 | |||
| 2010-06-30 | 4.31M shares 10-Q/A · filed 2011-09-09 | 4.30M shares 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |